Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.

about

Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.

Item

http://www.wikidata.org/entity/Q38616426

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Risk factors in patients under ...... risk childhood acute leukemia.

@en

type

Item

label

Risk factors in patients under ...... risk childhood acute leukemia.

@en

prefLabel

Risk factors in patients under ...... risk childhood acute leukemia.

@en

P1476

Risk factors in patients under ...... risk childhood acute leukemia.

@en

P2093

Dong-Mei Han

http://www.w3.org/2001/XMLSchema#string

Heng-Xiang Wang

http://www.w3.org/2001/XMLSchema#string

Hong-Min Yan

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Li Ding

http://www.w3.org/2001/XMLSchema#string

Ling Zhu

http://www.w3.org/2001/XMLSchema#string

Mei Xue

http://www.w3.org/2001/XMLSchema#string

Xiao-Li Zheng

http://www.w3.org/2001/XMLSchema#string

Zhi-Dong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Treatment of acute lymphoblastic leukemia.

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.

Current status of haploidentical stem cell transplantation for leukemia.

Unmanipulated or CD34 selected haplotype mismatched transplants.

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.

Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.

P2888

s12185-017-2317-y

P31

scholarly article

P356

10.1007/S12185-017-2317-Y

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091244428

http://www.w3.org/2001/XMLSchema#string

P698

28825215

http://www.w3.org/2001/XMLSchema#string